Share

ENDO 2018: Implanting Beta Cell-Seeded Biomaterial Restores Insulin Production in Type 1 Diabetes Mouse Model

Researchers have successfully created a novel biomaterial that can be seeded with insulin-producing beta cells. Implantation of the beta cell-seeded biomaterial reversed diabetes in a mouse model by effectively normalizing glucose levels and significantly increasing survival. The research results were presented Monday, March 19, at ENDO 2018, the annual 100th meeting of the Endocrine Society...
Share

ENDO 2018: Wearable Heart Rate Monitor Could Signal Low Blood Sugar in Type 1 Diabetes

A wearable medical patch measuring the beat-to-beat variation in heart rate is a promising device for the early detection of hypoglycemia, or low blood sugar, in type 1 diabetes, according to the researchers who tested the new monitor. Results of their preliminary study were presented Saturday at ENDO 2018, the Endocrine Society’s 100th annual meeting...
Share

FDA Approves New Continuous Glucose Monitoring System with Predictive Algorithm Technology

The U.S. Food and Drug Administration (FDA) has approved a new continuous glucose monitoring (CGM) system for people with diabetes ages 14 to 75 years. Medtronic is marketing the system as Guardian Connect, the first smart standalone CGM system to help people with diabetes stay ahead of high and low glucose events. The Guardian Connect...
Share

Canagliflozin Significantly Reduces the Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk for or With a History of Cardiovascular Disease

Late-breaking exploratory analysis from the CANVAS Program presented at the American College of Cardiology’s 67th Annual Scientific Session The results of  recent analysis showed that canagliflozin significantly reduced the risk of cardiovascular (CV) death or hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) at high CV risk. This exploratory analysis from...
Share

Endocrine Society, ADA, AACE, AADE Strongly Disagree with ACP’s Recent Diabetes Statement

Together, the Endocrine Society, the American Diabetes Association (ADA), the American Association for Clinical Endocrinologists (AACE), and the American Association of Diabetes Educators (AADE) strongly disagree with the American College of Physicians’ (ACP’s) proposed new guidance that suggests higher blood glucose targets for people with type 2 diabetes. While there is agreement on individualization of...

Diabetes Research Articles

Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.